Towards Cancer Patient Empowerment for Optimal Use of Antithrombotic Therapy at the End of Life

Informacje na temat projektu

SERENITY

Identyfikator umowy o grant: 101057292

DOI

10.3030/101057292

Data podpisania przez KE 24 Maja 2022

Data rozpoczęcia 1 Października 2022

Data zakończenia 30 Września 2027

Finansowanie w ramach

• Health

Koszt całkowity

€ 4 483 532,50

Wkład UE

€ 4 483 530,50

Koordynowany przez

ACADEMISCH ZIEKENHUIS LEIDEN
Netherlands

CORDIS oferuje możliwość skorzystania z odnośników do publicznie dostępnych publikacji i rezultatów projektów realizowanych w ramach programów ramowych HORYZONT.

Odnośniki do rezultatów i publikacji związanych z poszczególnymi projektami 7PR, a także odnośniki do niektórych konkretnych kategorii wyników, takich jak zbiory danych i oprogramowanie, są dynamicznie pobierane z systemu OpenAIRE .

Rezultaty

Documents, reports (2)

Midterm progress report on realist review

The midterm progress report will summarise the fundings half way the duration of this particular study. The final manuscript will be ready for submission by month 12. The results of the review are used to inform the creators of the shared decision support tool(WP5) as well as the methodology for the RCT (WP6).

Report on findings of the realist review on PROSPERO

This report will summarise the findings of the realist review. The results of the review are used to inform the creators of the shared decision support tool (WP5) as well as the methodology for the RCT (WP6).

Websites, patent fillings, videos etc. (1)

Project website and logo

Both a project logo and website will be designed as described in section 2.2 and launched within the first 3 months of the project.

Publikacje

Peer reviewed articles (10)

Use of antithrombotic therapy and the risk of cardiovascular outcomes and bleeding in cancer patients at the end of life: a Danish nationwide cohort study

Autorzy: Mette Søgaard, Marie Ørskov, Martin Jensen, Jamilla Goedegebuur, Eva K. Kempers, Chantal Visser, Eric C.T. Geijteman, Denise Abbel, Simon P. Mooijaart, Geert-Jan Geersing, Johanneke Portielje, Adrian Edwards, Sarah J. Aldridge, Ashley Akbari, Anette A. Højen, Frederikus A. Klok, Simon Noble, Suzanne Cannegieter, Anne Gulbech Ording
Opublikowane w: Journal of Thrombosis and Haemostasis, Numer 23, 2025, ISSN 1538-7836
Wydawca: Elsevier BV
DOI: 10.1016/J.JTHA.2024.09.023

Discontinuation of Anticoagulants and Occurrence of Bleeding and Thromboembolic Events in Vitamin K Antagonist Users with a Life-limiting Disease

Autorzy: Eva Kempers, Chantal Visser, Eric Geijteman, Jamilla Goedegebuur, Johanneke Portielje, Mette Sogaard, Anne Gulbech Ording, Carline van den Dries, Denise Abbel, Geert-Jan Geersing, Sarah Aldridge, Kate Lifford, Ashley Akbari, Sjef van de Leur, Melchior Nie
Opublikowane w: Thrombosis and Haemostasis, 2025, ISSN 0340-6245
Wydawca: Schattauer
DOI: 10.1055/A-2524-5334

“Who am I to say that I'm not going to take it”: patient perspectives on decisions about antithrombotic therapy in the context of advanced cancer

Autorzy: Elin Baddeley, Carme Font, Isabelle Mahé, Michelle Edwards, Stephanie Sivell, Kate J. Lifford, Victoria Mailen Arfuch, Nuri Coma-Auli, Mette Søgaard, Helle Enggaard, Hélène Helfer, Nassima Si Mohammed, Kathy Seddon, Mark Pearson, Simone P. Mooijaart, Sebastian Szmit, F.A. Klok, Simon Noble, Anette Arbjerg Højen
Opublikowane w: Thrombosis Research, Numer 253, 2025, ISSN 0049-3848
Wydawca: Elsevier BV
DOI: 10.1016/J.THROMRES.2025.109399

Anti‐thrombotic therapy in patients with cancer at the end of life and associated clinical outcomes: A cohort study using population‐linked routinely collected data

Autorzy: Sarah J. Aldridge, Ashley Akbari, Adrian Edwards, Kate J. Lifford, Denise Abbel, Suzanne Cannegieter, Jamilla Goedegebuur, Eva K. Kempers, Mette Søgaard, Chantal Visser, Geert‐Jan Geersing, Marieke J. H. Kruip, Anne Gulbech Ording, Carline van den Dries, Eric C. T. Geijteman, Erik Klok, Isabelle Mahé, Simon P. Mooijaart, Sebastian Szmit, Simon Noble
Opublikowane w: British Journal of Haematology, 2025, ISSN 0007-1048
Wydawca: Wiley
DOI: 10.1111/BJH.70032

Thrombosis Research

Autorzy: J, Goedegebuur; D, Abbel; F A, Klok; S I R, Noble
Opublikowane w: Scientia, 2023, ISSN 0049-3848
Wydawca: Pergamon Press
DOI: 10.1016/j.thromres.2023.05.008

Quality of vitamin K antagonist treatment during the last year of life

Autorzy: Chantal Visser, Eva K. Kempers, Jamilla Goedegebuur, Denise Abbel, Sarah J. Aldridge, Adrian Edwards, Michelle Edwards, Geert‐Jan Geersing, Anne Gulbech Ording, Sjef J. C. M. van de Leur, Kate J. Lifford, Isabelle Mahé, Simon P. Mooijaart, Melchior C. Nierman, Johanneke E. A. Portielje, Mette Søgaard, Sebastian Szmit, Nynke M. Wiersma, Simon I. R. Noble, Frederikus A. Klok, Qingui Chen, Suzanne C. Cannegieter, Eric C. T. Geijteman, Marieke J. H. A. Kruip, null null
Opublikowane w: HemaSphere, Numer 9, 2025, ISSN 2572-9241
Wydawca: Wiley
DOI: 10.1002/HEM3.70135

Discontinuation of Anticoagulants and Occurrence of Bleeding and Thromboembolic Events in Vitamin K Antagonist Users with a Life-limiting Disease

Autorzy: Eva K. Kempers, Chantal Visser, Eric C. T. Geijteman, Jamilla Goedegebuur, Johanneke E. A. Portielje, Mette Søgaard, Anne Gulbech Ording, Carline van den Dries, Denise Abbel, Geert-Jan Geersing, Sarah J. Aldridge, Kate J. Lifford, Ashley Akbari, Sjef J. C. M. van de Leur, Melchior C. Nierman, Isabelle Mahé, Simon P. Mooijaart, Sebastian Szmit, Michelle Edwards, Simon I. R. Noble, Frederikus A. Klok, Qingui Chen, Suzanne C. Cannegieter, Marieke J. H. A. Kruip, null null
Opublikowane w: Thrombosis and Haemostasis, 2025, ISSN 0340-6245
Wydawca: Georg Thieme Verlag KG
DOI: 10.1055/A-2524-5334

Understanding European patterns of deprescribing antithrombotic medication during end-of-life care in patients with cancer

Autorzy: E.S.L. Martens, D. Becker, C. Abele, D. Abbel, W.P. Achterberg, J.J. Bax, L. Bertoletti, M.E. Edwards, C. Font, A. Gava, J. Goedegebuur, A.A. Højen, M.V. Huisman, M.J.H.A. Kruip, I. Mahé, S.P. Mooijaart, M. Pearson, K. Seddon, S. Szmit, S.I.R. Noble, F.A. Klok, S.V. Konstantinides
Opublikowane w: Thrombosis Research, Numer 245, 2024, ISSN 0049-3848
Wydawca: Elsevier BV
DOI: 10.1016/j.thromres.2024.109205

Involving patients and the public in cancer associated thrombosis research: A strategy for success

Autorzy: Michelle Edwards, Kathy Seddon, Elin Baddeley, Anne Gulbech Ording, Mark Pearson, Isabelle Mahe, Simon Mooijaart, Frederikus A. Klok, Simon I.R. Noble
Opublikowane w: Thrombosis Update, Numer 18, 2025, ISSN 2666-5727
Wydawca: Elsevier BV
DOI: 10.1016/j.tru.2024.100196

Shared decision-making and deprescribing to support anti-thrombotic therapy (dis)continuance for persons living with cancer in their last phase of life: A realist synthesis

Autorzy: Justin Jagosh, Mark Pearson, Sarah Greenley, Anthony Maraveyas, Gamze Keser, Fliss E. M. Murtagh, Simon Noble, Michelle Edwards, Adrian Edwards, Anette Arbjerg Højen, Kathy Seddon, Frederikus A. Klok, Simon P. Mooijaart, Eric C. T. Geijteman, Miriam J. Johnson
Opublikowane w: PLOS Medicine, Numer 22, 2025, ISSN 1549-1676
Wydawca: Public Library of Science (PLoS)
DOI: 10.1371/JOURNAL.PMED.1004663